Dalrada is implementing plans to achieve cost savings and focusing on growing subsidiaries anticipated to be most profitable while reducing investments in less profitable areas. The company is pursuing synergistic opportunities including acquisitions to complement its Genefic segment.
Cyborg Score Rationale
The company faces substantial doubt about its ability to continue as a going concern due to significant operating losses and working capital deficits. Net loss was $(23.25) million, compared to $(20.63) million in the prior year. However, restructuring efforts are underway.
Top Insights
Revenue declined to $25.18 million from $29.74 million; gross profit fell to $5.81 million from $9.06 million, signaling operational contraction
Company announced cost reductions of $4.5 million aligned with business expectations and propelling towards profitability
Five operating divisions span climate technology (heat pumps, energy services), precision manufacturing (semiconductor deposition systems), healthcare (Genefic), and digital technologies (software engineering, blockchain)
Company faces multiple litigation challenges including fraud claims regarding Likido acquisition and breach of contract disputes
Named Competitors
Industrial heat pumps and energy solutions — Commercial HVAC and energy management
CVD/PVD deposition systems — Semiconductor processing equipment
Digital engineering and software services — IT consulting and digital engineering